BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7259957)

  • 1. Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro.
    Stratford IJ; Williamson C; Hardy C
    Br J Cancer; 1981 Jul; 44(1):109-16. PubMed ID: 7259957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitro.
    Millar BC; Jinks S; Powles TJ
    Br J Cancer; 1981 Nov; 44(5):733-40. PubMed ID: 7317272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
    Astor M; Hall EJ
    Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
    Ahmed I; Stratford IJ; Jenkins TC
    Arzneimittelforschung; 1985; 35(12):1763-8. PubMed ID: 4096727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal radiosensitizing and cytotoxic properties of ortho-substituted nitroimidazoles.
    Stratford IJ; Hoe S; Adams GE; Hardy C; Williamson C
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Jan; 43(1):31-43. PubMed ID: 6601069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents.
    Astor M; Hall EJ; Biaglow JE; Parham JC
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):75-83. PubMed ID: 7061257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination studies with misonidazole and a cis-platinum complex: cytotoxicity and radiosensitization in vitro.
    Stratford IJ; Williamson C; Adams GE
    Br J Cancer; 1980 Apr; 41(4):517-22. PubMed ID: 7190019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization of hypoxic mammalian cells in vitro by some 5-substituted-4-nitroimidazoles.
    Adams GE; Fielden EM; Hardy C; Millar BC; Stratford IJ; Williamson C
    Int J Radiat Biol Relat Stud Phys Chem Med; 1981 Aug; 40(2):153-61. PubMed ID: 6974144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased radiosensitivity of aerobic mammalian cells following pre-incubation with misonidazole in hypoxia.
    Michaels HB
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1271-4. PubMed ID: 6469749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains.
    Adams GE; Ahmed I; Clarke ED; O'Neill P; Parrick J; Stratford IJ; Wallace RG; Wardman P; Watts ME
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Dec; 38(6):613-26. PubMed ID: 6970731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential radiosensitizing agents. 7. 4(5)-Iodo-5(4)-nitroimidazole derivatives.
    Gupta RP; Larroquette CA; Agrawal KC; Grodkowski J; Neta P
    J Med Chem; 1985 Aug; 28(8):987-91. PubMed ID: 4020837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-targeted 2-nitroimidazoles: studies of the influence of the phenanthridine-linked nitroimidazoles, 2-NLP-3 and 2-NLP-4, on DNA damage induced by ionizing radiation.
    Buchko GW; Weinfeld M
    Radiat Res; 2002 Sep; 158(3):302-10. PubMed ID: 12175307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Fluorobenzylamine and phenylalanine methyl ester conjugates of 2-nitroimidazole: evaluation as hypoxic cell radiosensitizers.
    Garg PK; Garg S; Degraff WG; Zalutsky MR; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1992; 22(3):593-6. PubMed ID: 1531220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization of mammalian cells by transition metal complexes containing nitroimidazole ligands.
    Chibber R; Stratford IJ; Ahmed I; Robbins AB; Goodgame D; Lee B
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1213-5. PubMed ID: 6547935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azomycin riboside: a new radiosensitizer.
    Pedersen JE; Barron G; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC; Rupp WD; Rockwell S
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enhanced sensitivity of mammalian cells to killing by X rays after prolonged exposure to several nitroimidazoles.
    Hall EJ; Astor M; Biaglow J; Parham JC
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):447-51. PubMed ID: 7107367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some examples of anomalous radiosensitizing behaviour of electron-affinic compounds in vitro.
    Watts ME; Jacobs RS
    Br J Cancer Suppl; 1978 Jun; 3():80-3. PubMed ID: 277262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin.
    Panicucci R; Heal R; Laderoute K; Cowan D; McClelland RA; Rauth AM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloronitroimidazoles as radiosensitizers of hypoxic cells in vitro.
    Wideł M; Watras J; Suwiński J; Salwińska E
    Neoplasma; 1987; 34(3):241-51. PubMed ID: 3614460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.